Document center

“Voices from the Future - 30 years of Breakthrough Technologies in Europe”

Published on | 4 years ago

Programmes FET
“This booklet provides a snapshot of the first 30 years of FET. It explains the evolution of the programme, through testimonials of some of the people who shaped its policy aspects, examples of projects and their impact on technology and economy, and profiles of FET researchers, who have been listening out for “voices from the future”.” This publication was produced under the FETFX project, the Coordination and Support Action dedicated to communication and outreach of the Horizon 2020 Future and Emerging Technologies programme, with specific focus to FET Open and FET Proactive, now part of the Enhanced European Innovation Council Pilot (specifically the Pathfinder).

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.